Skip to main content

Peer Review reports

From: Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies

Original Submission
4 Jan 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
27 Feb 2024 Reviewed Reviewer Report
3 Oct 2024 Reviewed Reviewer Report
5 Oct 2024 Reviewed Reviewer Report - Zeinab Siami
12 Oct 2024 Reviewed Reviewer Report - Antonio Mastroianni
31 Oct 2024 Author responded Author comments - Franck F. Rahaghi
Resubmission - Version 3
31 Oct 2024 Submitted Manuscript version 3
2 Nov 2024 Author responded Author comments - Franck F. Rahaghi
Resubmission - Version 4
2 Nov 2024 Submitted Manuscript version 4
6 Nov 2024 Reviewed Reviewer Report
11 Nov 2024 Reviewed Reviewer Report - Antonio Mastroianni
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
12 Nov 2024 Editorially accepted
26 Nov 2024 Article published 10.1186/s12879-024-10211-8

You can find further information about peer review here.

Back to article page